Filter
1305
Filtered Results: 1305
Text search:
molecular
testing
Featured
Recommendations
173
New Publications
267
Language
Document type
No document type
608
Guidelines
279
Studies & Reports
236
Manuals
71
Strategic & Response Plan
58
Fact sheets
27
Training Material
14
Situation Updates
7
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
81
Global
44
Western and Central Europe
44
Latin America and the Carribbean
34
Kenya
28
Africa
24
Eastern Europe
24
South Africa
23
Tanzania
22
Ethiopia
20
Brazil
18
Germany
16
Nigeria
14
West and Central Africa
13
East and Southern Africa
13
Sierra Leone
12
Malawi
12
Rwanda
11
South–East Asia Region
11
Russia
11
Philippines
10
Uganda
10
Colombia
9
Peru
9
Zimbabwe
9
Zambia
9
Indonesia
9
Liberia
9
Nepal
8
Asia
8
Namibia
8
Mozambique
7
Congo, Democratic Republic of
7
Argentina
7
Bangladesh
6
Myanmar / Burma
6
Ukraine
5
Ghana
5
Syria
5
USA
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Angola
5
Senegal
4
Burkina Faso
4
Middle East and North Africa
4
Ecuador
4
Pakistan
4
El Salvador
3
Chile
3
Cambodia
3
Guinea-Bissau
3
Spain
3
Lebanon
3
Vietnam
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Tajikistan
2
Lesotho
2
Turkey
2
Benin
2
Cameroon
2
Guinea
2
Italy
2
Venezuela
2
North America
2
Bolivia
2
Georgia
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Gambia
1
Afghanistan
1
Haiti
1
Dominican Republic
1
Jordan
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Nicaragua
1
Palestine
1
Honduras
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
405
Clinical Guidelines
182
Pharmacy & Technologies
55
Public Health
50
Key Resources
27
Women & Child Health
19
Capacity Building
5
Toolboxes
TB
267
COVID-19
173
AMR
107
NTDs
88
HIV
86
Rapid Response
66
Ebola & Marburg
37
Mental Health
34
Planetary Health
27
Pharmacy
27
Zika
20
Refugee
16
NCDs
15
Polio
12
Specific Hazards
11
Health Financing Toolbox
8
Caregiver
6
Cholera
5
Malaria
5
Conflict
5
Natural Hazards
4
Disability
4
Global Health Education
2
Social Ethics
1
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
This study compared clinical and autopsy findings for three asbestos-related diseases (asbestosis, mesothelioma and lung cancer) in former asbestos mineworkers, and explored factors that influenced agreement between clinical and autopsy findings using data from two compensation systems. In South Afr...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos...
interim guidance, 25 November 2024
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended...
The SAARC Member States have more than an estimated 2.0 million TB cases accounting for close to one-third of the total cases of TB in the world. India alone had almost one-fifth of the global disease burden due to TB. India, Pakistan and Bangladesh followed by Afghanistan are the major contributors...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
New edition
Abbreviated Report of a WHO Consultation
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Taeniasis and cysticercosis caused by the parasite T. solium affect vulnerable populations,
mainly in Latin America, sub-Saharan Africa and Asia, where pigs (the intermediate host) roam
free and poor sanitation allows pigs access to human faeces.
The Bolivarian Republic of Venezuela has been facing a sociopolitical and economic situation that has negatively impacted social and health indicators. There have been intensified population movements both within the country and to other countries, particularly to Argentina, Brazil, Chile, Colombia,...
